ASLN
Morgan Stanley’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-8,700
| Closed | -$2.61K | – | 8155 |
|
|
2024
Q2 | $2.61K | Hold |
8,700
| – | – | ﹤0.01% | 7020 |
|
|
2024
Q1 | $5.35K | Sell |
8,700
-40,700
| -82% | -$25K | ﹤0.01% | 6877 |
|
|
2023
Q4 | $25.8K | Buy |
49,400
+20,442
| +71% | +$10.7K | ﹤0.01% | 6569 |
|
|
2023
Q3 | $54.4K | Hold |
28,958
| – | – | ﹤0.01% | 6134 |
|
|
2023
Q2 | $106K | Sell |
28,958
-1,200
| -4% | -$4.38K | ﹤0.01% | 5931 |
|
|
2023
Q1 | $86.9K | Sell |
30,158
-120,636
| -80% | -$347K | ﹤0.01% | 6071 |
|
|
2022
Q4 | $54.3K | Sell |
150,794
-189
| -0.1% | -$68 | ﹤0.01% | 6253 |
|
|
2022
Q3 | $91K | Sell |
150,983
-103,967
| -41% | -$62.7K | ﹤0.01% | 6133 |
|
|
2022
Q2 | $127K | Sell |
254,950
-242,022
| -49% | -$121K | ﹤0.01% | 6148 |
|
|
2022
Q1 | $447K | Buy |
496,972
+246,153
| +98% | +$221K | ﹤0.01% | 5476 |
|
|
2021
Q4 | $281K | Buy |
250,819
+11,311
| +5% | +$12.7K | ﹤0.01% | 5881 |
|
|
2021
Q3 | $426K | Buy |
239,508
+8,049
| +3% | +$14.3K | ﹤0.01% | 5591 |
|
|
2021
Q2 | $764K | Buy |
231,459
+187,393
| +425% | +$619K | ﹤0.01% | 5243 |
|
|
2021
Q1 | $148K | Sell |
44,066
-37,211
| -46% | -$125K | ﹤0.01% | 5820 |
|
|
2020
Q4 | $148K | Buy |
81,277
+79,382
| +4,189% | +$145K | ﹤0.01% | 5740 |
|
|
2020
Q3 | $3K | Sell |
1,895
-7,501
| -80% | -$11.9K | ﹤0.01% | 6539 |
|
|
2020
Q2 | $18K | Sell |
9,396
-3,483
| -27% | -$6.67K | ﹤0.01% | 6038 |
|
|
2020
Q1 | $13K | Sell |
12,879
-5,703
| -31% | -$5.76K | ﹤0.01% | 5962 |
|
|
2019
Q4 | $37K | Buy |
+18,582
| New | +$37K | ﹤0.01% | 5939 |
|